The Strategic Clinical Innovation Organization (SCIO) method is explicitly designed to help pharmaceutical innovators address their concerns and maneuver around evolving challenges. SCIO identifies time and cost efficiencies and relief from risk management on their journey to market approval. Reach out today to learn more.

An early-phase strategy improves productivity and the path to market approval.

SCIO SM Advantages

• Accelerate Patient Recruitment
• Reduce Patient Number
• Reduce Clinical Development Time
• Reduce Trial Monitoring Time
• Increase Patient Retention
• Facilitate Decision Making
• Increase Data Quality

The FDA has been calling for a smarter, more innovative process for market approval, and SCIO SM is the integrative, multidisciplinary approach to deliver it.

Click to Learn More about SCIO

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

CAPTCHA

Comments

This field is for validation purposes and should be left unchanged.